Trulieve Cannabis (TCNNF) Common Equity (2020 - 2026)

Trulieve Cannabis' Common Equity history runs 7 years deep, the most recent figure standing at $1.1 billion for Q1 2026.

• In Q1 2026, Common Equity fell 5.71% year-over-year to $1.1 billion; the TTM figure through Mar 2026 stood at $1.1 billion (down 5.71% YoY), while the FY2025 annual figure was $1.1 billion, down 8.49% from the prior year.
• Common Equity was $1.1 billion for Q1 2026 at Trulieve Cannabis, up from $1.1 billion in the prior quarter.
• In the past five years, Common Equity ranged from a high of $2.1 billion in Q2 2022 to a low of $1.1 billion in Q4 2025.
• Historically, Common Equity has averaged $1.5 billion across 5 years, with a median of $1.4 billion in 2024.
• The sharpest annual moves came in 2022 and 2023: Common Equity surged 336.42% in 2022, then plunged 31.04% in 2023.
• A 5-year view of Common Equity shows it stood at $1.9 billion in 2022, then slipped by 26.93% to $1.4 billion in 2023, then decreased by 11.33% to $1.2 billion in 2024, then declined by 8.49% to $1.1 billion in 2025, then advanced by 0.55% to $1.1 billion in 2026.
• The last three Common Equity figures came in at $1.1 billion (Q1 2026), $1.1 billion (Q4 2025), and $1.2 billion (Q3 2025), per Business Quant data.